This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAJQ5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,848.80 firm-fixed-price delivery order is for the supply of Veklury (remdesivir) 100 mg vials, a critical medication used in the treatment of COVID-19.
The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, encompasses a wide array of essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas.
The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, is responsible for fulfilling this order for the Veklury medication. The delivery of these critical COVID-19 treatment vials supports the federal government's efforts to ensure the availability of essential medical supplies for military personnel, veterans, and other federal beneficiaries.
Generated 4/10/25, 11:31 AM